Skip to content
March 29, 2024

Equity.Guru

Investment information for the new generation

Search

Hepion Pharmaceuticals

Hepion Pharmaceuticals (HEPA.Q) today announced positive topline results from its Phase 2a ‘AMBITION’ NASH clinical trial. Additionally, all primary endpoints of the trial were met. “In order to embark…